Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

CRDL

Cardiol Therapeutics (CRDL)

Cardiol Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:CRDL
일자시간출처헤드라인심볼기업
2024/02/2700:06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
2024/02/2121:29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
2024/02/1603:15AllPennyStocks.comOrphan Drug Designation Sends Shares of this Dual-Listed Life Science Therapy Company SoaringNASDAQ:CRDLCardiol Therapeutics Inc
2024/02/1521:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
2024/01/2421:29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
2024/01/0921:31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
2023/12/0521:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
2023/11/1620:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
2023/11/0120:29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
2023/10/2106:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
2023/10/1123:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
2023/10/1019:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
2023/09/2620:28Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
2023/09/2023:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
2023/09/1920:29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
2023/08/1106:13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
2023/08/0921:21Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
2023/08/0820:38Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
2023/06/3000:45Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
2023/06/3000:44Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
2023/06/2720:29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
2023/05/1905:04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
2023/05/1605:55Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
2023/03/2920:29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
2023/03/2919:02Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CRDLCardiol Therapeutics Inc
2023/03/0721:29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
2022/12/1221:32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
2022/11/2017:35TipRanksCardiol Therapeutics (CRDL) Receives a Rating Update from a Top AnalystNASDAQ:CRDLCardiol Therapeutics Inc
2022/11/2017:15TipRanksCanaccord Genuity Sticks to Their Buy Rating for Cardiol Therapeutics (CRDL)NASDAQ:CRDLCardiol Therapeutics Inc
2022/11/1507:35Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
 검색 관련기사 보기:NASDAQ:CRDL